Is CV or EDAP more undervalued in 2026?

CirclFi compares CapsoVision, Inc. (CV) and EDAP TMS S.A. (EDAP) using 13 institutional-grade valuation models. CV has a Quality of Company score of 5.7/10 while EDAP scores 3.1/10.

Which is a better buy — CV or EDAP?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CV and EDAP valuations compare?

CV at $6.78 and EDAP at $4.32 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CV vs EDAP Valuation Comparison 2026 — Intrinsic Value Analysis

CV

Electromedical & Electrotherapeutic Apparatus

CapsoVision, Inc.

Quality

5.7

out of 10

Value Trap

—

Price

$6.78

Last close

Models

10/13

Active

EDAP

Electromedical & Electrotherapeutic Apparatus

EDAP TMS S.A.

Quality

3.1

out of 10

Value Trap

LOW

Price

$4.32

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	CV Fair Value	CV Upside	EDAP Fair Value	EDAP Upside
Bayesian DCF	Intrinsic	$0.14	-98.0%	$0.85	-80.2%
Earnings Power Value	Intrinsic	$0.32	-95.7%	$2.40	-30.8%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CV vs EDAP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CV vs EDAP — Which Stock Is More Undervalued?

CV scores higher with a 5.7/10 quality rating vs EDAP's 3.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing CapsoVision, Inc. (CV) and EDAP TMS S.A. (EDAP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CV currently trades at $6.78 with a QOC of 5.7/10, while EDAP trades at $4.32 with a QOC of 3.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).